An 84-year-old man left clinicians at a Hong Kong hospital utterly perplexed after arriving at the hospital to be treated […] ...

Leprosy rarely occurs in Ireland, with most of the diagnosed cases being people who were infected outside the country. In ...

Arctic therapeutics raises funding from EIC Fund, Kaldbakur, and Sanos Group to advance its dementia treatment, AT-001, and acne drug, AT-004. The company aims to transform the treatment landscape for ...

Sanofi and Regeneron's Dupixent has become the first biologic drug to show activity in prurigo nodularis (PN), raising the hope of a new treatment option for the rare and highly debilitating skin ...

Skinvisible granted Quoin an exclusive, royalty-bearing license to its technology for use in select rare skin diseases and for the right to use its proprietary formula for Netherton Syndrome.

Report recommended that strategies should be developed to prioritise ongoing education for healthcare professionals to ...

A 38-year-old British woman has been battling aggressive Stage 4 terminal melanoma—skin cancer—for the past eight years, ...

Skinvisible granted Quoin an exclusive, royalty-bearing license to its technology for use in select rare skin diseases and for the right to use its proprietary formula for Netherton Syndrome.

Skinvisible granted Quoin an exclusive, royalty-bearing license to its technology for use in select rare skin diseases and for the right to use its proprietary formula for Netherton Syndrome.

For the first time since 2018, the Navesink River was frozen enough for ice boaters to take their crafts out on the solid ...

For the uninitiated, the alphabet BBL might draw a blank. Not so for aspiring and practising socialites in our big capital ...